Skip to main content
OpenTrials
Completed

NCT Number: NCT05524467

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients

Vifor International Inc. is seeking real-world evidence (RWE) to better understand the epidemiology, patient characteristics, and management of CKD-aP in the real-world clinical setting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Kidney Disease-associated Pruritus

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

1113, Aschaffenburg, Germany

Loading trial locations.

About this study

This is a non-interventional, cross-sectional, multicentre, and multinational (European) study. The non-interventional study (NIS) design allows the observation of patients in large haemodialysis (HD) centres reflecting routine clinical practice. All decisions on therapeutic or diagnostic procedures, treatments, management of the disease, or resource utilisation will be at the full discretion of the treating physician without interference by the sponsor or study protocol. All treatment decisions will follow the real-life treatment behaviour.

The CENSUS-EU represents a cross-sectional study design of a representative selection of patients undergoing HD at 113 large dialysis centres across 7 countries in Europe. Prot. v.2.0, 9 May 2023

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female adult patients with CKD (≥18 years) receiving HD for at least 3 months prior to signing informed consent
  • Signed informed consent
  • Able and willing to fill in questionnaires

Exclusion criteria

  • Patients performing HD at home or both home and centre

Treatment and study plan

Primary outcomes

  1. Prevalence of CKD-aP in HD patients

    Time frame: A 7-month study timeline

    Percentage (%)

Secondary outcomes

  1. The prevalence of CKD-aP by severity

    Time frame: A 7-month study timeline

    none, mild, moderate, and severe

Sponsors and collaborators

Lead sponsor

Vifor (International) Inc.

Industry

Registry information

Official study title

RELIEF CENSUS-EU: Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients

Acronym: ReliefCensus

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Sep 1, 2022
Registry last updated
Jul 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.